Aethlon Medical (AEMD) Cash from Financing Activities (2010 - 2026)

Aethlon Medical's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$196496.0 for Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 108.33% year-over-year to -$196496.0; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (down 15.6% YoY), and the FY2026 full-year result was $6.5 million, down 15.6% from the prior year.
• Cash from Financing Activities was -$196496.0 for Q1 2026 at Aethlon Medical, down from $3.0 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for AEMD reached as high as $8.3 million in Q3 2022 and fell as low as -$196496.0 in Q1 2026.
• Median Cash from Financing Activities over the past 5 years was $42572.0 (2024), compared with a mean of $1.4 million.
• Across the five-year window, Cash from Financing Activities surged 97728.44% in 2025 and plunged 108.33% in 2026, its largest moves.
• Over 5 years, Cash from Financing Activities stood at -$1884.0 in 2022, then jumped by 9501.75% to $177129.0 in 2023, then sank by 103.99% to -$7073.0 in 2024, then jumped by 42269.31% to $3.0 million in 2025, then sank by 106.59% to -$196496.0 in 2026.
• Business Quant data shows AEMD's Cash from Financing Activities at -$196496.0 in Q1 2026, $3.0 million in Q4 2025, and $3.7 million in Q3 2025.